HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,045-1,056 of 4,505
Drug study icon
CompletedNCT07359209

Berberine Improving Cognitive Impairments in Schizophrenia

Official study title

Study on the Mechanism s of Berberine Improving Cognitive Impairments in Schizophrenia Based on Gut-brain Axis

This study has finished and is no longer accepting participants.

In Tianjin
SchizophreniaMedication studyAges 18–65
Countries
China
Sponsor
Tianjin Anding Hospital
Drug study icon
CompletedNCT07268430

Bioequivalence Study of Long-Acting Paliperidone Palmitate in people with Schizophrenia

Official study title

A Multicenter, Randomized, Open-Label, Parallel-Group, Multiple-Dose Bioequivalence Study of Paliperidone Palmitate Injection in Chinese Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Beijing
SchizophreniaMedication studyAges 18–65
Countries
China
Sponsor
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Drug study icon
TerminatedNCT05662306

C-Cog in Early Course Schizophrenia Study

Official study title

Comprehensive Treatment of Early Course Schizophrenia: A Nonrandomized Study of Long Acting Injectable Antipsychotic Medication Combined With Cognitive and Functional Skills Training

This study ended early.

In Miami
SchizophreniaMedication studyAges 18+
Countries
United States
Sponsor
University of Miami
Behavioral study icon
CompletedNCT06061952

CAE for Poorly Adherent Individuals With Schizophrenia

Official study title

Prospective 12-week Randomized Controlled Trial (RCT) of Remotely- Delivered Customized Adherence Enhancement for Poorly Adherent Individuals With Schizophrenia (CAE-S) vs Enhanced Treatment as Usual (eTAU)

This study has finished and is no longer accepting participants.

In Cleveland
SchizophreniaBehavioural studyAges 18+
Countries
United States
Sponsor
University Hospitals Cleveland Medical Center
Other study type icon
TerminatedNCT03608137

Cannabis and Thought Disorder in Schizophrenia

Official study title

Cannabis and Thought Disorder in Schizophrenia: Clinical and Neuroimaging Relationships

This study ended early.

In Bron
SchizophreniaInterventional studyAges 18–65
Countries
France
Sponsor
Hôpital le Vinatier
Behavioral study icon
CompletedNCT02686697

Carnosine and Cognitive Training in Schizophrenia

Official study title

A Double-blind, Placebo-controlled Study on the Effects of Combined L-Carnosine and Cognitive Training on Cognition in Schizophrenia

This study has finished and is no longer accepting participants.

In New York
SchizophreniaMedication studyAges 18–60
Countries
United States
Sponsor
Abraham Reichenberg

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.